CASE OF DEVELOPMENT OF NON-HODGKIN'S MALIGNANT LYMPHOMA ON THE BACKGROUND OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WHO SUFFERED OF THE CHORNOBYL ACCIDENT.

Authors :: Dyagil IS
Sholoyko VV
Silayev YO
Martina ZV
Dmytrenko IV
Tovstogan AO
Fedorenko VG
Shlyakhtychenko TY
Minchenko ZM
Source :: Problemy radiatsiinoi medytsyny ta radiobiolohii [Probl Radiac Med Radiobiol] 2018 Dec; Vol. 23, pp. 517-523.
Publication Year :: 2018
Abstract: In this paper, a clinical case of combination of chronic myeloid leukemia and T-lymphoblastic lymphoma is present-ed, which is currently a rather rare finding for a clinician. The diagnosis of T-lymphoblastic lymphoma is establishedafter 2 years from the verification of chronic myeloid leukemia. The course of diseases and approaches to treatmentare described.The pathogenetic relationship between myeloid and lymphoid diseases remains unclear and is likely to be the resultof several factors - radiation, chemical and, consequently, genetic disorders.<br /> (I. S. Dyagil, V. V. Sholoyko, Yu. O. Silayev, Z. V. Martina, I. V. Dmytrenko, A. O. Tovstogan, V. G. Fedorenko, T. Yu. Shlyakhtychenko, Zh. M. Minchenko.)

Subjects :: Antineoplastic Combined Chemotherapy Protocols therapeutic use
Cyclophosphamide therapeutic use
Doxorubicin therapeutic use
Female
Humans
Hydroxyurea administration & dosage
Hydroxyurea adverse effects
Imatinib Mesylate therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive complications
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive etiology
Lymphoma, T-Cell complications
Lymphoma, T-Cell drug therapy
Lymphoma, T-Cell etiology
Middle Aged
Prednisone therapeutic use
Radiation, Ionizing
Treatment Outcome
Ukraine
Vincristine therapeutic use
Antineoplastic Agents therapeutic use
Chernobyl Nuclear Accident
Environmental Exposure adverse effects
Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology
Lymphoma, T-Cell pathology
Radiation Exposure adverse effects

Full Text Access

Tools